Home

Warburg Pincus Private Equity IX, L.P.

CIK 1332737 · last filed 2020-11-20

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.44B

Companies

8

Total Filings

19

Lifetime Open-Market Net

-$8.83B

Filer Profile

Reported Address
C/O WARBURG PINCUS LLC
450 LEXINGTON AVENUE
NEW YORK, NY 10017
Phone
(212) 878-0600
Related Filers
PINCUS & CO. WARBURG — 114 joint filings, latest 2020-11-20
CHARLES R KAYE — 108 joint filings, latest 2016-05-25
Joseph P. Landy — 108 joint filings, latest 2016-05-25
WARBURG PINCUS LLC — 108 joint filings, latest 2016-05-25
Warburg Pincus IX LLC — 99 joint filings, latest 2014-12-19
Warburg Pincus Partners LLC — 99 joint filings, latest 2014-06-06
WPM GP, LLC — 25 joint filings, latest 2013-02-15
WPM, L.P. — 25 joint filings, latest 2013-02-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Vital Energy, Inc. (LPI) Delisted Director 2,297,392 $48.09 $110.48M -$2.67B 6 2020-11-20
ARMK Director 6,517,070 $58.55 $381.57M -$6.16B 3 2015-05-29
BLDR 10%+ Owner 24,613,907 $60.37 $1.49B $6.67M 3 2012-03-09
Ceres, Inc. (CERE) Delisted Director 288,462 $44.96 $12.97M $0 1 2012-02-28
FIS Director 41,124,148 $38.14 $1.57B $0 2 2011-09-07
INSPIRE PHARMACEUTICALS INC (ISPH) Delisted 10%+ Owner 0 — — $0 1 2011-05-16
Metavante Technologies, Inc. (MV) Delisted 10%+ Owner 29,779,553 — — $0 1 2008-12-16
NYFIX INC (NYFX) Delisted 10%+ Owner 3,325,227 — — $313.5K 2 2008-07-02

Recent Filings · Page 2 of 2

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2011-12-21 Vital Energy, Inc. (LPI) Delisted Other (J) +1,136,703,960 $0 EDGAR
2011-09-07 FIS Grant (A) +390,960 $3.9K EDGAR
2011-05-16 INSPIRE PHARMACEUTICALS INC (ISPH) Delisted U −160,352,416 -$801.76M EDGAR
2010-09-17 FIS Grant (A) +692,397 $6.9K EDGAR
2008-12-16 Metavante Technologies, Inc. (MV) Delisted Other (J) +23,580 $236 EDGAR
2008-07-02 NYFIX INC (NYFX) Delisted Other (J) +3,675,000 $0 EDGAR
2008-03-12 BLDR Buy (P) +248,654 $1.62M EDGAR
2008-03-11 NYFIX INC (NYFX) Delisted Buy (P) +79,800 $313.5K EDGAR
2007-03-16 BLDR Buy (P) +277,095 $4.55M EDGAR
Showing 11–19 of 19
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.